The incidence of brain metastasis (BM) is high in patients with ... Novel agents, such as EGF receptor (EGFR) tyrosine kinase inhibitors (TKIs), have now been included in standard non-small ...
Anaplastic lymphoma kinase (ALK)-positive non-small cell ... with 12-month PFS rates of 78% for those with brain metastases, compared to only 22% for crizotinib[1][2]. This indicates that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback